Cerus Corporation to Participate in the 17th Annual Craig-Hallum Alpha Select Conference
Business Wire•11/11/2026•08:30 ET
0
Key Highlights
- ➤Cerus management to host investor meetings at Craig-Hallum Alpha Select Conference
- ➤INTERCEPT Blood System for platelets and plasma holds CE mark and FDA approval
- ➤INTERCEPT Fibrinogen Complex approved in U.S. for bleeding associated with fibrinogen deficiency
- ➤INTERCEPT red blood cell system under European regulatory review and U.S. late-stage development
Cerus Corporation to Participate in the 17(th) Annual Craig-Hallum Alpha Select Conference
Cerus Corporation (Nasdaq: CERS) announced today that members of the Company’s management will participate in and host one-on-one investor meetings at the 17(th) Annual Craig-Hallum Alpha Select Conference taking place in New York City on Tuesday, November 17.
Get started
Create a free account to read the full story.